P., Day, C
3,4 American Association of Clinical Endocrinology guidelines recommend treatment with GLP-1RA in T2DM patients with coexisting ASCVD, high-risk for ASCVD, heart failure, or chronic kidney disease regardless of their glycemic control due to their organ protective effects
Recent Posts How to Use Global DRO Substance Consideration Process How does a substance or method get considered for the WADA Prohibited List
However, it is the long-term complications that pose significant risks to health, including: Cardiovascular Disease : Diabetes significantly raises the risk of a number of cardiovascular issues, such as atherosclerosis, strokes , heart attacks , and coronary artery disease with angina (chest discomfort)
Being prescribed Ozempic for type 2 diabetes or cardiovascular risk reduction
Gummies can spike blood sugar and are usually packed with fillers